Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Working Groups Hot Topics

PHUSE collaborations are organised into a number of specialist Working Groups, each with a broad topic area. The Working Groups have specific projects designed to achieve a set of particular objectives.

 

This page will highlight the latest news and information from our projects. Participation is open to anyone who wants to contribute and if you would like to get involved, please

email:

email workinggroups@phuse.global.

Community Forum 

Thank you to all attendees! 

The Emerging Trends & Technologies Working Group hosted the latest Community Forum:
Ingestion and Standardisation of Real-World Data. This free, virtual event took place 5 October 2022. 

Couldn't attend? Ensure you don't miss out! Catch up by viewing the recording.

We encourage everyone to get involved in the online Disqus forum. Here, you can have your say, ask the presenters questions and carry on the conversation. 


PHUSE/FDA CSS 2024

Registration for the PHUSE/FDA CSS 2024 is open!

Come and be a part of the PHUSE/FDA Computational Science Symposium 2024 (CSS) taking place 3–5 June in Silver Spring, MD. Share your insights, discoveries and solutions with the PHUSE Community, who are eager to learn and collaborate. 

Status
colourBlue
titleRegister Here


Calling For Feedback

The Good Transparency Practices project within the Data Transparency Working Group, is now calling for feedback! This White Paper aims to define a set of best practices for data transparency and create a Good Transparency Practices guidance. The best practices will aim to ensure anonymised data is compliant with the legal requirements as defined by Regulators, as well as preserves as much data utility as possible.

Please send in your comments to workinggroups@phuse.global by 3 May.



Recently Published Deliverables

Visit the PHUSE website to view the extensive list of all published deliverables.

The Cloud Adoption in the Life Sciences Industry project, within the Emerging Trends & Technologies Working Group, has recently published an updated version of the Cloud Audit Activities which makes up part of the Cloud Framework Documents. The framework for cloud adoption consists of different papers. The paper related to the assessment/audit of cloud service providers has been updated to reflect current thinking. This includes more focus on assessment rather than physical audits. View the paper here

The SDTM ADaM Implementation FAQ project, part of the
New Deliverables

Image Added

The Best Data Practices for Rare Disease Patient Foundations and Researchers within the Real World Evidence Working Group, has published a new deliverable in the form of a poster. The poster provides an overview of Ensuring Registry Data Relevance and Reliability for Regulatory Use

The PHUSE data standards community, which is comprised of leaders and experts responsible for the governance and implementation of data standards across the biopharmaceutical industry, have authored and new White Paper. The Data Standards White Paper highlights current challenges in data standardisation across the biopharma industry and identify opportunities where we can work together to tackle them.


The SDTM ADaM Implementation FAQ within

Optimizing the Use of Data StandardsWorking Group

, has

have published

two new responses to questions they received under SDTM/ADaM IG Nuances and Data Submissions. The questions are in relation to submitting a custom ADaM dataset and transgender patients in clinical trials. Image RemovedProjects Calling for VolunteersThe Office of New Drugs (OND) in the FDA Center for Drug Evaluation and Research (CDER) released two documents in early September for public review, on standard adverse event groupings and queries for evaluation of biologic/new drug applications. The Safety Analytics Working Group are still seeking members to join their brand-new project which aims to provide consolidated feedback on these documents.
There is only 1 week left to provide your comments as all feedback will need to be collected by24 Octoberto submit to the FDA! For more information on how to get involved, please email workinggroups@phuse.global.

BIMO FAQ – It was apparent during the creation of the PHUSE Bioresearch Monitoring Data Reviewer's Guide (BDRG) that organisations implementing BIMO Submission packages have outstanding questions. The aim of this project is to develop a BIMO Frequently asked Questions Forum on the PHUSE Advance Hub. The forum will utilise the questions brought forward by the pharma/CRO community via public review, presentations, PHUSE BIMO team members, etc...
To get involved, please contact workinggroups@phuse.global

Best Data Practices for Rare Disease Patient Foundations and Researchers, part of the Emerging Trends & Technologies Working Group, is looking for members to join their project to create a guidance about best data practices for patient foundations and for researchers in the form of decision trees, graphics, short printable materials or videos. Please contact workinggroup@phuse.global for more information. 

a new FAQ! The question they have answered is 'Naming Convention for Split RS Domain', you can view this question and the teams response viaValidation/Conformance Rules page. You can see all the FAQ this project has answered so far via here.

Do you have a SDTM ADaM question? You can send your questions to the team by emailing workinggroups@phuse.global.


Volunteer Opportunities

Image Added

The Data Visualisation & Open Source Technology Working Group has a new project, Demonstrating Real-World Impact of Modernization of Statistical Analytics (MSA) Framework.This project aims to extend the MSA framework by creating a reference architecture that takes into account real-world scenarios and design solutions to remediate them, ultimately providing a practical guide to building an end-to-end validated environment for regulated work. Companies seeking to build an open-source programming environment for regulatory reporting can leverage the MSA framework for guidance. However, since the framework is designed to be both flexible and extensible, implementing it may prove challenging for companies, resulting in situations where risks are not sufficiently mitigated. While the original MSA paper provided conceptual guidance, the PHUSE handover of the project will seek to provide an overview of practical implementations of the framework being applied.

This project is calling for volunteers, to join contact workinggroups@phuse.global by 26 April.


The Safety Analytics Working Group is looking for a new Working Group Lead to join their team. This Working Group is a cross-disciplinary collaboration working to improve the content and implementation of clinical trial safety analyses for medical research, leading to better data interpretations and increased efficiency in the clinical drug development and review processes.

Click here to see a list of current projects within this Working Group.

Learn more about the roles and the responsibilities of a Working Group Lead and apply by emailing workinggroups@phuse.global. Closing date 26 April.


Multiple projects within Working Groups are open to join. PHUSE welcomes new members who can apply their knowledge to bring fresh ideas and contribute to the ongoing work of PHUSE projects. For more information, click here, read the Welcome Pack or email workinggroups@phuse.global


PHUSE Communications 

Working Groups Report: Includes project updates, recent and upcoming deliverables and future plans for each Working Group.

Monthly Mailings: The monthly newsletter. Here you will find a full update from each month of the year, easily accessible and divided into key areas of PHUSE.

PHUSE Blogs: Fancy a quick read? A blog is a perfect way to catch up on all things Working Groups. Get the lowdown on the latest events from across the globe and stay updated on industry topics brought to you by industry professionals. 


New Project Idea? 
Project Idea?

Initiate and lead a new project under the PHUSE Working Groups umbrella. The new project must address problems of significant relevance to computational science related to drug,

biologic

biological and device development and must meet all of the guidelines for projects within the collaboration, including the following mandatory requirements: 

  • The projects must address significant research issues relevant to Computational Science
  • The project must not attempt to address FDA policy issues
  • There must be at least one Project Lead personally involved in planning and carrying out the project

New projects can be submitted anytime during the year, click here to submit

PHUSE Communications 

Working Groups Latest Report Q2 2022: The report includes project updates, recent and upcoming deliverables and the future plans for each Working Group.

Monthly Mailings: Our monthly newsletter. Here you will find a full update from each month of the year, easily accessible and divided into key areas of PHUSE.

PHUSE Blogs: Fancy a quick read? A blog is the perfect way to catch up on all things Working Groups. Get the lowdown on the latest events from across the globe and stay updated on industry topics bought to you by industry professionals